Covered recipient · General Payments record
ANDREW PATRICK AMBROSY
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2022–2025
$71,638.32
- Reported across 55 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $35,633.75 | 8 |
| Travel and Lodging | $8,490.47 | 6 |
| Food and Beverage | $1,218.17 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $24,469.70 | 7 |
| Novo Nordisk AS | $6,832.66 | 6 |
| E.R. Squibb & Sons, L.L.C. | $5,252.50 | 1 |
| Merck Sharp & Dohme Corporation | $4,268.54 | 6 |
| PFIZER INC. | $3,900.00 | 2 |
| ABIOMED | $202.58 | 1 |
| SCPHARMACEUTICALS INC. | $166.64 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $160.85 | 2 |
| American Regent | $49.46 | 1 |
| CVRx Inc. | $39.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2025 202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $202.58 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174747455 | CMS |
| American Regent | $49.46 | 09/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200849854 | CMS |
| CVRx, Inc. | $39.46 | 03/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219176032 | CMS |
| E.R. Squibb & Sons, L.L.C. | $5,252.50 | 11/04/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1184523403 | CMS |
| Merck Sharp & Dohme LLC | $42.87 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237997018 | CMS |
| Merck Sharp & Dohme LLC | $36.15 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237998340 | CMS |
| Merck Sharp & Dohme LLC | $336.00 | 09/02/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1238034312 | CMS |
| Merck Sharp & Dohme LLC | $183.52 | 09/03/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1238003388 | CMS |
| Merck Sharp & Dohme LLC | $3,520.00 | 09/17/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1238007084 | CMS |
| Merck Sharp & Dohme LLC | $150.00 | 09/17/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1238035518 | CMS |
| Novartis Pharmaceuticals Corporation | $66.43 | 03/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200199351 | CMS |
| Novartis Pharmaceuticals Corporation | $94.42 | 10/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200097336 | CMS |
| Novo Nordisk AS | $97.01 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189187051 | CMS |
| Novo Nordisk AS | $785.00 | 04/01/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1189187095 | CMS |
| Novo Nordisk AS | $325.73 | 04/29/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1189186135 | CMS |
| Novo Nordisk AS | $15,503.75 | 04/29/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1189186267 | CMS |
| Novo Nordisk AS | $262.99 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189187041 | CMS |
| Novo Nordisk AS | $6,863.88 | 04/29/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1189187065 | CMS |
| Novo Nordisk AS | $631.34 | 04/29/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1189187219 | CMS |
| Novo Nordisk Inc | $3,140.00 | 03/18/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1188525006 | CMS |
| Novo Nordisk Inc | $60.32 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189041371 | CMS |
| Novo Nordisk Inc | $45.17 | 03/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188850624 | CMS |
| Novo Nordisk Inc | $17.22 | 09/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189048091 | CMS |
| Novo Nordisk Inc | $37.45 | 11/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188236694 | CMS |
| Novo Nordisk Inc | $3,532.50 | 11/11/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1188746255 | CMS |
| PFIZER INC. | $2,600.00 | 11/13/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1229756917 | CMS |
| PFIZER INC. | $1,300.00 | 11/13/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1229954864 | CMS |
| SCPHARMACEUTICALS INC. | $166.64 | 09/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228200388 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.